ALTRIA GROUP, INC.(MO)— Stock Profile, AI Score & Financials
Consumer Staples · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
ALTRIA GROUP, INC. (MO) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores MO at 67.4/100 on a 32-signal composite quality model, placing it at rank #365 of 2,961 stocks — the top 25% of the AI-ranked universe. MO scores in the top quartile across balance sheet strength (97.2), revenue scale (93.5), free cash flow (90.3). Areas of concern include revenue growth (18.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), ALTRIA GROUP, INC. reports quarterly revenue of $6.1B, net income of $2.3B, an operating margin of 51.3%. Top institutional holders of MO by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. MO trades on the NYSE exchange and files with the SEC under CIK 764180. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ALTRIA GROUP, INC. directly from SEC EDGAR.
AI Quality Score
67.4/100
AI Rank
#365
Revenue
$6.1B
Net Income
$2.3B
Free Cash Flow
$662.0M
Operating Margin
51.3%
MO key financials by period
ALTRIA GROUP, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$23.3B
$6.9B
42.5%
FY 2024
10-K
$24.0B
$11.3B
46.8%
FY 2023
10-K
$24.5B
$8.1B
47.2%
FY 2022
10-K
$25.1B
$5.8B
47.5%
FY 2021
10-K
$26.0B
$2.5B
44.4%
FY 2020
10-K
$26.2B
$4.5B
41.6%
Institutions holding MO
Institutional investors reporting a position in ALTRIA GROUP, INC. on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-07-30 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net revenues were essentially flat at $6,111M as smokeable pricing offset a 5.3% oral tobacco decline, while reported operating income fell 2.9% to $3,136M on USSTC consolidation and litigation charges.
Biggest Revenue Drivers
Smokeable products$5,392M+0.7% YoY
Higher pricing ($309 million), which includes higher promotional investments, partially offset by volume/cigarette mix ($279 million)
Share of the nicotine pouch category was 14.4%, down 1.7 points versus prior year
All other$6M
Includes e-vapor (NJOY), Horizon and Helix International
Largest Expense Items
Cost of sales$1,536M+6.7% YoY
USSTC Facilities Consolidation costs, higher manufacturing costs and higher per unit settlement charges, partly offset by lower shipment volume
Excise taxes on products$755M-7.0% YoY
Lower smokeable shipment volume and higher refunds of taxes and duties paid on imported cigarettes
Marketing, administration and research costs$663M+7.1% YoY
Higher tobacco and health litigation items and higher general corporate expenses, partly offset by lower amortization
Interest and other debt expense, net$295M+$20M YoY
Includes $24 million of litigation-related interest costs
Margins: Smokeable reported OCI margin fell 1.0 pp to 63.1% (adjusted margin rose 0.3 pp to 64.8%), while oral tobacco reported OCI margin fell 13.2 pp to 55.2% on $78 million of USSTC Facilities Consolidation costs.
Watch Items from the Filing
Oral tobacco retail share fell 3.7 points to 29.0%; Copenhagen cans -10.9% and Skoal -13.7%, with Skoal trademark fair value exceeding carrying value by only 7% ($0.3 billion).
USSTC Facilities Consolidation: total pre-tax charges estimated at approximately $180 million, with $78 million incurred in the quarter and completion expected in the first quarter of 2028.
Individual smoking and health cases rose to 247 as of July 27, 2026 from 195 a year earlier; quarterly litigation charges were $91 million and accrued liability reached $156 million.
Discount retail share of the cigarette category reached 33.8%, up 2.6 points YoY, as Marlboro share fell 1.5 points to 39.5% and discount shipments rose 67.3%.
State Settlement Agreement and FDA user fee charges are estimated at $3.0 billion on average for the next three years; $2.6 billion was paid in the first six months of 2026.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
